LCE 50 (Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg)

Pill imprint LCE 50 has been identified as Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa, entacapone and levodopa

Imprint:

LCE 50

Strength:

12.5 mg / 200 mg / 50 mg

Color:

Brown

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.